SOLLINI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 3.618
AS - Asia 2.818
EU - Europa 947
SA - Sud America 514
AF - Africa 123
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 8.036
Nazione #
US - Stati Uniti d'America 3.516
SG - Singapore 1.661
CN - Cina 527
BR - Brasile 419
VN - Vietnam 285
FI - Finlandia 175
IT - Italia 168
IE - Irlanda 136
DE - Germania 107
IN - India 77
GB - Regno Unito 72
SE - Svezia 67
NG - Nigeria 63
CA - Canada 58
HK - Hong Kong 58
FR - Francia 53
AR - Argentina 46
NL - Olanda 38
BD - Bangladesh 30
IQ - Iraq 27
MX - Messico 25
RU - Federazione Russa 25
ES - Italia 19
PL - Polonia 17
TR - Turchia 16
ZA - Sudafrica 14
BE - Belgio 13
CL - Cile 12
JP - Giappone 12
ID - Indonesia 11
IR - Iran 11
AT - Austria 10
EC - Ecuador 10
IL - Israele 10
PK - Pakistan 10
UZ - Uzbekistan 10
CO - Colombia 9
TN - Tunisia 9
UA - Ucraina 9
EU - Europa 8
SA - Arabia Saudita 8
KG - Kirghizistan 7
LT - Lituania 7
MY - Malesia 7
VE - Venezuela 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
JM - Giamaica 6
MA - Marocco 6
PH - Filippine 6
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
PE - Perù 5
AZ - Azerbaigian 4
CH - Svizzera 4
HR - Croazia 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SY - Repubblica araba siriana 3
EE - Estonia 2
KR - Corea 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 8.035
Città #
Singapore 729
Ashburn 490
San Jose 329
Chandler 280
The Dalles 240
Wilmington 225
Shanghai 215
Helsinki 175
Dallas 168
Beijing 161
San Mateo 147
New York 144
Dublin 135
Boardman 122
Ho Chi Minh City 108
Ann Arbor 91
Benin City 63
Lawrence 60
Princeton 60
Los Angeles 59
Santa Clara 57
Hanoi 56
Hong Kong 51
Milan 51
Pune 42
Leawood 41
London 39
Amsterdam 34
São Paulo 34
Toronto 29
Paris 28
Buffalo 26
Fairfield 26
Da Nang 25
Seattle 24
Brooklyn 23
Woodbridge 23
Monmouth Junction 21
Haiphong 19
Phoenix 18
Rio de Janeiro 16
Warsaw 16
Belo Horizonte 15
Montreal 14
Orem 14
Boston 13
Brussels 13
Florence 13
Redwood City 13
Baghdad 12
Naples 12
Rome 12
Falkenstein 11
Johannesburg 11
Stockholm 11
Manchester 10
Moscow 10
Munich 10
Tashkent 10
Atlanta 9
Brasília 9
Curitiba 9
Mexico City 9
Norwalk 9
Porto Alegre 9
Campinas 8
Chicago 8
San Francisco 8
Tokyo 8
Chennai 7
Kocaeli 7
Santiago 7
Zhengzhou 7
Bishkek 6
Des Moines 6
Redmond 6
Reston 6
Sorocaba 6
Vienna 6
Addis Ababa 5
Biên Hòa 5
Calgary 5
Charlotte 5
Council Bluffs 5
Denver 5
Düsseldorf 5
Fortaleza 5
Goiânia 5
Hangzhou 5
Ipatinga 5
Kuala Lumpur 5
Munro 5
Nairobi 5
Osasco 5
Pittsburgh 5
Quito 5
San Diego 5
Tel Aviv 5
Amman 4
Andover 4
Totale 5.157
Nome #
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 126
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 124
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 122
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 121
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 104
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 102
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 97
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 97
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 96
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 95
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 93
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 92
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 90
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 90
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 89
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 89
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 87
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 87
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 86
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 86
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 86
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 84
PET/CT radiomics in breast cancer: Mind the step 84
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 83
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 82
Cardiac molecular pathways influenced by doxorubicin treatment in mice 81
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 80
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 80
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 80
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 80
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 79
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 78
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 76
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 75
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 75
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 75
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 75
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 74
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 74
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 74
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 73
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 72
Radiomics of Liver Metastases: A Systematic Review 72
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 72
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 71
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 71
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 70
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 69
Methodological framework for radiomics applications in Hodgkin’s lymphoma 69
18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study 68
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 67
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 67
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 67
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 66
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 64
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 63
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 62
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 61
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 61
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 60
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 60
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 59
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 59
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective 58
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 58
Alternative Nuclear Imaging Tools for Infection Imaging 57
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 56
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 56
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 55
[18F]FDG-PET/CT texture analysis in thyroid incidentaloma: preliminary results 55
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors 55
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 54
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 54
PET/MRI in Infection and Inflammation 54
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 54
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 53
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 53
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 53
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 52
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 52
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 51
Total glycolytic volume and biological markers in mesothelioma patients 51
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 50
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 49
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 49
Current Status of Molecular Imaging in Infections 48
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 47
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 47
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 46
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 46
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 45
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis 45
Nuclear Medicine Imaging of Spondylodiscitis: The Emerging Role of PET 45
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 44
Combined imaging approach to diagnose a meningioma in a patient with prostate and lung cancers 43
The role of imaging in the diagnosis of recurrence of primary seminal vesicle adenocarcinoma 43
Biomarkers in well differentiated thyroid cancer 43
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 43
New approaches for imaging and therapy of solid cancer 43
Miniaturized Radiochemical Purity Testing for 99mTc-HMPAO, 99mTc-HMDP and 99mTc-Tetrofosmin 42
Totale 6.920
Categoria #
all - tutte 54.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022426 55 5 25 85 16 7 8 45 35 23 101 21
2022/20231.030 136 54 79 71 84 45 10 108 186 107 127 23
2023/20241.076 71 109 211 81 38 169 80 44 29 19 94 131
2024/20251.378 37 7 12 16 16 165 78 91 248 319 176 213
2025/20263.756 574 224 182 350 145 198 1.046 199 233 218 167 220
Totale 8.172